Announcements Trials
Browse Landscape

Phase

Phase 1 5Phase 2 3Phase 1/2 2Phase 4 1Phase 3 1

Status

Completed 3Terminated 1Recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Tumor-Agnostic 3Thoracic 1Sarcoma 1Lymphoid 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Neoplasms 5Lung Neoplasms 5Brain Neoplasms 3Prostatic Neoplasms 2Esophageal Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Hepatocellular 2Thoracic Neoplasms 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Osteosarcoma 1Neuroblastoma 1Neoplasms by Site 1Mesothelioma, Malignant 1Melanoma 1Lymphoma 1Lung Diseases 1Gastric Adenocarcinoma 1Detection Rate of SLN ; Accuracy Rate of Lymph Node Metastasis 1Breast Neoplasms 1

Interventions

pembrolizumab 82Paclitaxel 71Gemcitabine 66Carboplatin 61Cisplatin 46Docetaxel 44Bevacizumab 41Nivolumab 33Irinotecan 31Fluorouracil 29Pemetrexed 28Cyclophosphamide 26Cetuximab 26Capecitabine 26Erlotinib Hydrochloride 22venetoclax 21trametinib 21Leucovorin 20Sorafenib 17Albumin-Bound Paclitaxel 17Afatinib 17130-nm albumin-bound paclitaxel 17Topotecan 16Radiotherapy 16Oxaliplatin 16fludarabine 15regorafenib 14budigalimab 14atezolizumab 14Ipilimumab 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 1 × Neoplasms × Indocyanine Green × Clear all
NCT04084067 2026-04-30

Indocyanine Green (ICG) Guided Tumor Resection

St. Jude Children's Research Hospital

Phase 1 Recruiting
230 enrolled
CNSGastrointestinalGenitourinaryLymphoidSarcoma

Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Lymphoma, Neoplasms, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma

NCT02111824 2021-09-17

MIMIG

The Methodist Hospital Research Institute

Phase 1 Terminated
7 enrolled
Thoracic

Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Site, Thoracic Neoplasms

NCT02280954 2018-03-20

818012

University of Pennsylvania

Phase 1 Completed
48 enrolled
Tumor-Agnostic

Neoplasms

NCT02621268 2018-03-20

ICG

University of Pennsylvania

Phase 1 Completed
48 enrolled
Tumor-Agnostic

Neoplasms

NCT01884584 2017-03-09

Potential Use of Indocyanine Green as a Fluorescent Agent for Definition of Surgical Margins in Cancer

Emory University

Phase 1 Completed
24 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡